Key Insights

Highlights

Treatment Research

1 treatments under study, led by Sodium Thiosulfate And Methylene Blue Solution

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Sodium Thiosulfate And Methylene Blue Solution1

Active Sponsors

  • Affiliated Hospital to Academy of Military Medical Sciences1

Top Investigators

Related Conditions

  • Gastrointestinal Neoplasms1

Activity Timeline